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Background: Radiation therapy is one of the most effective therapeutic tools for brain metastasis. However, it is
inevitable that some cancer cells become resistant to radiation. This study is focused on the identification of genes
associated with radioresistance in metastatic brain tumor from lung cancer and the functional examination of the
selected genes with regards to altered sensitivity of cancer cells to radiation.
Methods: After establishing radioresistant cells from the xenograft model, we explored the significant
transcriptional changes by performing DNA microarray profiling. Functional analyses in vitro and in vivo performed
to validate the gene responsible for radioresistance.
Results: Transcriptional changes induced by radiation therapy are much more extensive in H460 cells than in
PC14PE6 cells. The expression levels of TopBP1 and Claspin were increased in the cancer cells that survived
radiation therapy. Depletion of TopBP1 or Claspin using shRNA showed an enhancement of sensitivity to radiation
in radioresistant lung cancer cells (PC14PE6). Moreover, increased levels of TopBP1 or Claspin endowed cells a
higher resistance to radiation. In xenograft models, the knock-down of TopBP1 or Claspin significantly prolonged
the median survival time post radiation therapy.
Conclusions: We analyzed the gene expression profiles of the radiosensitive cells and the radioresistant cells to
define a set of genes that may be involved in endowing lung cancer cells radioresistance post brain metastasis.
Functional analyses indicated that the expression TopBP1 and Claspin positively affects the survival of cancer cells
and thus negatively the xenograft metastasis model animals in response to radiation. These results show that
TopBP1 and Claspin can be potential targets for the enhanced efficacy of radiotherapy.
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Brain metastases occur in 20 to 40% of all patients with
cancer [1]. The problem is particularly challenging for
lung cancer patients as they often present with multiple
brain metastases. Even though multiple chemotherapeutic
agents have been studied for treatment of metastatic brain
tumors (MBTs), their clinical availability and effectiveness
are still limited. In these circumstances, whole-brain radi-
ation therapy has been used in the management of brain* Correspondence: nsnam@skku.edu; hyoo@skku.edu
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unless otherwise stated.metastases [1]. In fact, radiation therapy or stereotactic ra-
diosurgery often turn out to be the only available tools in
the cases of multiple MBTs. However, the frequent resist-
ance to radiation resulting in recurrence leads to treat-
ment failure in a substantial fraction of MBT patients.
Recently, various checkpoint mechanisms have received
much attention in association with genetic damages from
UV light or ionizing radiation (IR). DNA damage check-
points are important parts of signal-transduction pathways
that delay or arrest cell cycle progression in response to
the damage. Originally, checkpoints aid maintaining gen-
omic integrity and cell survival. However, these mecha-
nisms can be used by cancer cells to evade apoptosis from
DNA injury, resulting in acquiring resistance to irradiation
[2,3]. There are several reports suggesting that the check-
point can be exploited to enhance radiosensitivity [4,5]. Asd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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is an essential co-activator of ATR [6]. In addition, this
protein has a direct and essential role in the pathway that
connects ATM to ATR [7]. Claspin was identified as a
Chk1-interacting protein and an important regulator of
Chk1 activation [8,9].
Cells with functionally defective components of DNA
damage checkpoint pathways show cell cycle checkpoint
defects, and an increased sensitivity to IR and other DNA
damage agents [2,10]. This latter observation highlights
components of these DNA damage checkpoint pathways
as potential therapeutic targets for enhancing the sensi-
tivity of tumor cells to the radiotherapeutic agents [11].
Tumor cell specific checkpoint mechanisms for DNA
damage in response to IR can thus provide clues to
problems of radioresistance.
In the present study, we sought to genes associated with
radioresistance in metastatic brain tumor and to investi-
gate how they can be targeted for enhanced susceptibility
of carcinoma cells to radiation. We analyzed the gene ex-
pression profiles of lung cancer cells with and without ra-
diation treatment using xenograft models of lung cancer
brain metastasis. We found that the expression levels ofFigure 1 Induction of radioresistant cells in vivo. (A) Clonogenic surviv
indicated. Two lung cancer cell lines (PC14PE6 and H460) were exposed to
for the generation of radioresistant lung cancer cells in lung cancer brain m
were xenografted into a mouse brain to produce orthotopic metastasis mo
PC14PE6, 15 and 20 Gy). (C-D) The H460 (C) and PC14PE6 (D) cells from th
radiation as indicated. After exposure to IR, cell survival was evaluated by c
independent experiments and error bars represent the standard deviation.TopBP1 and Claspin were significantly increased in the sur-
viving cancer cells after radiation therapy compared to un-
treated cells. Consistently, depletion of TopBP1 or Claspin
in lung cancer cells showed an enhancement of sensitivity
to radiation. In xenograft models, the knock-down of
TopBP1 or Claspin significantly prolonged the median sur-
vival time in response to radiotherapy. Therefore TopBP1
and Claspin are potential therapeutic targets for overcom-
ing the limitation of radiotherapy for MBT.
Results and discussion
Induction of radioresistance using lung cancer brain
metastases xenograft
We assessed radiosensitivity of lung cancer cell lines
(PC14PE6 and H460) with various doses of radiation. The
clonogenic survival assays revealed that both cell lines
showed clear radiation sensitivity in a dose-dependent man-
ner, and the survival fraction of PC14PE6 showed 0.4 at
2.5 Gy whereas the survival fraction of H460 cells was more
severely reduced down to 0.04 at 2.5 Gy (Figure 1A). These
reduced radiation sensitivity of PC14PE6 indicated that
PC14PE6 cells were relatively more resistant to radiation
than H460 cells. We made lung cancer brain metastasesal assays were performed with ionizing radiation (IR) treatment as
IR and the survival was measured. (B) Cartoon shows the procedure
etastasis xenograft model. Each lung cancer cells (PC14PE6 and H460)
del animals which were irradiated at various doses (H460, 5 and 10 Gy;
e mouse brain were cultured in vitro, and exposed to various doses of
ell proliferation assay (CCK-8 assay). Values are from at least three
*P-value < 0.05; **P-value < 0.005.
Choi et al. Molecular Cancer 2014, 13:211 Page 3 of 8
http://www.molecular-cancer.com/content/13/1/211xenograft models using PC14PE6 and H460 cells and
tested whether tumor cells in xenograft models acquired
radioresistance after radiotherapy. As shown in Figure 1B,
xenografted mice models were exposed to radiation once,
and the tumor cell mass was excised and cultured in vitro
again. To validate whether radiosensitivity of tumor cells
were changed, the tumor cells were irradiated with a range
of radiation doses (5–20 Gy). Survival representing resist-
ance to radiation was examined by cell proliferation assay
and shown by percent of viability to non-irradiated cells
(Figure 1C & D). Initially H460 cells have been less resist-
ant to radiation, but cells from irradiated tumor cells
(H460-5Gy and H460-10Gy) acquired radioresistance of
over 90% of the survival rate (Figure 1C). H460-10Gy cells
were even more radioresistant than H460 and H460-5Gy.
These results show that radiosensitive H460 cells acquired
radioresistance in a dose dependent manner. However,
PC14PE6, originally more radioresistant than H460 did
not show additional increase of resistance regardless of
the radiation dose (Figure 1D).
Alteration in gene expression profiles
After establishing radioresistant cells from the xenograft
model, we explored the significant transcriptional changes
by performing DNA microarray profiling. Using a filter
criterion of at least 2-fold change with p < 0.05, the num-
bers of genes with changes in expression in H460-10Gy
and PC14PE6-20Gy cells were determined: 385 genes in-
creased and 329 genes decreased in H460 while 76 genes
increased and 98 genes decreased in PC14PE6. Between
the two cell lines, 64 of the increased genes and 63 of the
decreased genes overlapped. These results are presented
in a Venn diagram (Figure 2A). In particular, the number
of affected genes in H460-10Gy cells was 4.1 fold higher
than that in PC14PE6-20Gy. These results showed that
transcriptional changes induced by radiation therapy are
more extensive in radiosensitive cells (H460) than in
resistant cells (PC14PE6). Functional annotation of the
genes was carried out using gene ontology-based bio-
logical property analysis. The genes were categorized into
15 functional groups (Figure 2B & C). Most of the chan-
ged genes in the two cell lines were associated with cell
differentiation, proliferation and cell cycle. The genes with
significant changes in expression are listed in Additional
file 1: Table S1-S4.
Enhanced radiosensitivity from depletion of TopBP1 and
Claspin
Genes involved in cellular response to DSBs are the
major targets for cancer cell death [12]. Specifically,
functional defects in DNA damage checkpoint pathways
show an increased sensitivity to radiation [2,10,13],
which led us to focus on the DNA Damage response
(DDR) signaling pathway for subsequent analyses. Thegenes with expression change in DNA damage check-
point pathway are listed in Additional file 1: Table S5.
Notably, genes from H460-10Gy outnumber those from
PC14E6-20Gy. We chose TopBP1 and Claspin genes as
our targets for functional analysis as they play important
roles for activating Chk1 in DDR pathway [6,8,14]. In
particular, since Chk1 inhibition using inhibitors showed
an enhancement of radiation sensitivity [13,15], it is
worth analyzing the role of genes upstream to Chk1 with
regards to radiosensitivity. Chk1 is a well-established
ATR target involved in DDR and normal cell cycle pro-
gression and thus represents a potential pharmacological
target in the development of anti-cancer therapeutic
agents [16,17].
To confirm and validate the findings obtained from our
microarray analysis, we used the radioresistant PC14PE6
cells and established stable lines in which TopBP1 and
Claspin were regulated by shRNA via doxycycline treat-
ment. It was confirmed that the mRNA levels of the two
genes decreased by doxycycline treatment compared to un-
treated PC14PE6 cells (Additional file 1: Figure S1A & B).
Induction of shRNA virtually completely abolished the ex-
pression of TopBP1 and Claspin (Figure 3A). It has been
shown that TopBP1 and Claspin play an essential role
in Chk1 activation/phosphorylation in response to DNA
damage [6,14]. We next examined the phosphorylation
of Chk1 in response to irradiation after knockdown of
TopBP1 and Claspin. As shown in Figure 3A, depletion
of TopBP1 or Claspin abolished Chk1 phosphorylation
as previously reported [6,7,14]. Immunocytochemistry
of γ-H2AX and TopBP1 demonstrated that γ-H2AX
foci were significantly decreased and the signals for
TopBP1 were scantly detected after the depletion of
TopBP1 (Additional file 1: Figure S1C).
We performed clonogenic survival assay to measure
the change in sensitivity to radiation in these stable cell
lines. The PC14PE6/shLuc cells showed a similar sensi-
tivity to irradiation in comparison to original PC14PE6
cells (Figure 3Ba). TopBP1 and Claspin knockdown cells
showed a higher sensitivity than control cells. The de-
crease in survival was particularly dramatic at higher
dose of IR (e.g. 4 Gy) than at lower dose of IR (< 2 Gy)
for both PC14PE6/shTopBP1 and PC14PE6/shClaspin
cells (Figure 3Bb & c). Our results are consistent with a
previous report describing an enhanced susceptibility to
radiation in cells with down-regulated Chk1 [13].
Enhanced radioresistance in cells from overexpression of
TopBP1 or Claspin
The expression levels of TopBP1 and Claspin increased
in induced radioresistant H460-10Gy cells. To clarify
and further evaluate their roles with radioresistance,
TopBP1, Claspin, and Chk1 were overexpressed in three
independent cell lines, H460, H23, and U2OS which are
Figure 2 Expression microarray analysis of two induced radioresistant cell lines. (A) Venn diagram shows the number of genes with
expression change by radiotherapy in PC14PE6 or H460 cells from xenografted models. Genes were selected using a filter criterion of at least
2-fold change compare to no radiotherapy control with p < 0.05. (B-C) Genes with altered expression in radioresistant H460-10Gy and
PC14PE6-20Gy are categorized into 15 functional groups based on the gene ontology. The gene numbers are displayed in graphs.
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& Additional file 1: Figure S2). The overexpression of
each gene was examined by immunoblot (Figure 3C).
In clonogenic assay, GFP expression vector was used
as a control. In H460 and H23 cells, overexpressingTopBP1 showed higher survival (over 50%) than con-
trol cells after 2 Gy IR exposure (Figure 3D). In U2OS,
the number of surviving colonies increased by about
20% compared to the control. These results indicate
that overexpression of TopBP1, Claspin, and Chk1
Figure 3 Depletion of TopBP1 or Claspin enhances radiosensitivity of PC14PE6 cells in vitro. (A) TopBP1, Claspin, and luciferase knock-down
cells are regulated by doxycycline treatment through Tet On/Off system. The cells expressing luciferase shRNA were used as a control. To
knockdown the target genes, the radio-resistant PC14PE6/shRNA cells were treated with doxycycline (1 μg/ml) for 72 hours and exposed to
10 Gy of IR. The protein levels were evaluated by Western blotting. The phosphorylation of Chk1 S317 and Chk2 Thr68 were induced by exposure
of radiation. TopBP1 and Claspin protein levels were significantly down-regulated with the treatment of doxycycline. (B) Cell survival was measured by
clonogenic survival assay in TopBP1 or Claspin down-regulated stable PC14PE6 cells with IR treatment as indicated. (C) For overexpression of TopBP1,
Claspin, or Chk1, overexpression plasmids were transfected into H460 (a), H23 (b), and U2OS (c) cells. The expression of each protein was shown by
Western blot. α-tubulin was used as the loading control. (D) Overexpression of Chk1, TopBP1 or Claspin enhances radioresistance in vitro. Expression
vector of each gene was transfected into three kinds of cell lines. The transfected (a) H460 cells, (b) H23 cells, and (c) U2OS cells were irradiated at 2 Gy.
Radiosensitivity was evaluated by clonogenic assay. Each experiment in triplicates was repeated three times. Error bars represent the standard deviation.
*P-value < 0.05; **P-value < 0.005.
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data.
Extended survival of brain metastasized mice by TopBP1
or Claspin knockdown
Based on results from in vitro functional assays, we hypoth-
esized that TopBP1 or Claspin would be potential target
genes in lung cancer brain metastasis models (Figure 4).
We thus sought to estimate the effects of TopBP1 and
Claspin knockdown based on the survival of lung cancer
brain metastasis xenograft model animals in response to ir-
radiation. We produced orthotopic xenograft animals withFigure 4 Knockdown of TopBP1 or Claspin extended survival of brain
irradiation (15 Gy) was performed after 2 weeks. TopBP1 or Claspin express
dose of 1 mg/kg from day 12. (B) Kaplan-Meier plot comparing survival of
combination group, and n = 8 for shTopBP1 group) (a) and PC14PE6/shClas
with indicated treatments. (C) The table presents the survival time of the m
cells under indicated conditions.injection of PC14PE6/shTopBP1 or PC14PE6/shClaspin
cells into the brain of athymic nude mice. Tumor-bearing
mice were treated with doxycycline and/or radiation ther-
apy as illustrated (Figure 4A). As shown in Figure 4B,
without irradiation, there was no difference in survival
rates between TopBP1-inhibited (i.e. doxycycline-treated)
group and TopBP1-expressing group. The median survival
time was 19 days. In contrast, when irradiated, xeno-
grafted mice with inhibited expression of TopBP1 showed
a higher survival rate than the control mice with the mean
life span of 42 days post injection (Figure 4C). In case of
Claspin knockdown mouse, the survival also extendedmetastasized mice. (A) Schedule of treatment. Whole brain
ion was inhibited for 5 days with doxycycline in drinking water at a
PC14PE6/shTopBP1 (n = 7 for control, n = 6 for sham-irradiated and
pin (n = 10 for each group) (b) orthotopic brain metastases models
ice that were injected with TopBP1 or Claspin down-regulated tumor
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fect was not as dramatic as in the case of TopBP1 knock-
down. Lung cancer brain metastasis models in this study
do not represent patients completely. Radiotherapy did not
mimic patient dosing and fractionation schedules for limi-
tation of animal models. In sum, xenotransplant analysis
further confirmed the proposed role of TopBP1 or Claspin
in DDR response and acquisition of radioresistance.
Conclusions
In this study, we comparatively analyzed the gene expres-
sion profiles of the radiosensitive cells and the radioresis-
tant cells to define a set of genes that may be involved in
endowing lung cancer cells radioresistance post brain me-
tastasis. Functional analyses in vitro and in vivo indicated
that the expression TopBP1 and Claspin positively affects
the survival of cancer cells and thus negatively the xeno-
graft metastasis model animals. This is consistent with re-
sults from our previous study which demonstrated elevated
expression levels of DNA damage checkpoint genes in
radioresistant lung cancer cell lines compared to the levels
in radiosensitive cell lines [18]. The expression pattern of
DNA damage checkpoint genes thus could be useful for
diagnosis and prognosis of brain metastasis and be promis-
ing targets for overcoming the radio-resistance in brain
metastasis.
Methods
Cell culture and cell lines
Human non-small cell lung cancer (NSCLC) cell lines H23,
H460, and human osteosarcoma cell (U2OS) (American
Type Culture Collection) were maintained in RPMI 1640
medium containing 10% fetal bovine serum, 100 U/ml
penicillin, and 100 μg/ml streptomycin, and PC14PE6,
kindly provided by MD Anderson Cancer Center was
maintained in Eagle’s minimal essential medium (MEM)
containing 10% fetal bovine serum, 100 U/ml penicillin,
and 100 μg/ml streptomycin at 37 °C and 5% CO2. Cell
lines were regularly tested for mycoplasma infection using
the MycoAlert mycoplasma detection kit (Lonza). Isolated
PC14PE6 and H460 cells from xenograft mouse brains
were immediately used to assay for the cell viability after
dissociation procedure.
Transfection and stable cell lines
For overexpression of TopBP1, Claspin, and Chk1 in H23,
H460 or U2OS cell lines, each cell lines were transfected
with expression vectors by electroporation using Cell Line
Nucleofector® Kit V with the Amaxa Nucleofector I system
(Lonza). Stable cell lines of tetracycline-regulated expres-
sion of a short hairpin RNA were generated as previously
described [13]. For shRNA induction, cells were seeded
to achieve 30%-50% confluency on the day of inductionand doxycycline was added into the culture medium at
1 μg/ml.
Western blotting
Cells were lysed and prepared for Western blotting ana-
lysis as previously described [19]. Anti-Chk1 and anti-
α-tubulin antibodies were purchased from Santa Cruz
Biotechnology. Anti-Claspin, anti-Chk1 phospho-Ser317,
anti-Chk2 phospho-Thr68 and anti-γ-H2AX antibodies
were obtained from Cell Signaling Technology. Anti-TopBP1
was obtained from Abcam. The secondary antibodies
Cy3-conjugated anti-mouse IgG and FITC-conjugated
anti-rabbit IgG for immunofluorescence were purchased
from Jackson Immunoresearch.
RNA interference
siRNAs were obtained from Genolution Pharma, Korea.
The sequences of the siRNAs targeting TopBP1 were: #1,
CAGAAUUGUUGGUCCUCAAdTdT and #2, CGAUA
GAGGAGACUCAUGAdTdT. The sequences of Claspin
siRNA 1 and siRNA 2 were GGAAAGAAAGGCAGCCA
GAdTdT and CCUUGCUUAGAGCUGAGUCdTdT, re-
spectively. The control luciferase siRNA sequence was
GTTACGCTGAGTACTTCGAAA. After the test of
mRNA knockdown efficacy, plasmids expressing shRNA
were constructed by shRNA cloning service from
Genolution.
Cell proliferation assay and clonogenic survival assay
Cell proliferation was analyzed with Cell Counting Kit 8
(Dojindo Molecular Technology) and clonogenic sur-
vival assay was performed as previously described [13].
Cell proliferation was expressed as a percentage of the
absorbance obtained in irradiated cells relative to that in
untreated control cells. Each experiment in triplicates
was repeated three times. Error bars represent the stand-
ard deviation.
Orthotopic lung cancer brain metastases xenograft
studies
All experiments were conducted in accordance with the
Institute Laboratory Animal Research Guide for the Care
and Use of Laboratory Animals and within the protocols
approved by the appropriate Institutional Review Boards
at the Samsung Medical Center (Seoul, Korea). Female
athymic nude mice, 7 weeks of age were used for this
study. Production of orthotopic lung cancer brain metas-
tases models were performed as previously described
[13]. Mock-irradiated or irradiated mice were anesthe-
tized with 100 mg/kg ketamine and 10 mg/kg xylazine
and restrained in custom-designed mice jig. Whole brain
irradiation (15 Gy) was performed after 2 weeks. To in-
duce knockdown of TopBP1 and Claspin, doxycycline,
which was formulated in 5% sucrose, was administered
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cells implantation at a dose of 1 mg/ml.
RNA expression array and data analysis
RNA expression array was performed as previously de-
scribed [18]. RNA was transcribed into cDNA and hybrid-
ized onto Affymetrix GeneChip HG-U133Plus2.0 according
to the Affymetrix GeneChip Expression Analysis Technical
Manual. The gene expression CEL files were normalized
using the Robust Multichip averaging procedure. The
dataset was normalized using Central Tendency Median
Normalization. Expression array data were deposited at
http://tbi.skku.edu/microarray/smc/yoo-20140106.
Statistical analysis
The survival analysis of xenograft model was performed
using the Kaplan-Meier and log rank tests (SPSS statis-
tical software, version 18.0). Increasing life span (ILS, %)
compared to median survival of negative control was
calculated, and statistical comparison was analyzed with
one-way analysis of variance (ANOVA) followed by the
lease significant difference (LSD) test. In vitro experi-
mental data were obtained from experiments repeated
three times with triplicates. Mean values were calculated
and significance was determined using the Student’s two
tailed test. P values < 0.05 were considered statistically
significant.
Additional file
Additional file 1: Supplementary Methods, Table S1-S5, and
Figure S1-S2.
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